INTEC PHARMA LTD. Proceeds from Common Stock Issued
INTEC PHARMA LTD. reported Proceeds from Common Stock Issued of $421.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2021-05-17
- INTEC PHARMA LTD. proceeds from issuance of common stock for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- INTEC PHARMA LTD. proceeds from issuance of common stock for the quarter ending 2020-09-30 was $0.00.
- INTEC PHARMA LTD. proceeds from issuance of common stock for the quarter ending 2020-06-30 was $0.00.
- INTEC PHARMA LTD. proceeds from issuance of common stock for the quarter ending 2020-03-31 was $421.00K.
- INTEC PHARMA LTD. proceeds from issuance of common stock for fiscal 2020 was $421.00K, a 79.82% decline from fiscal 2019.
- INTEC PHARMA LTD. proceeds from issuance of common stock for fiscal 2019 was $2.09M, a 94.04% decline from fiscal 2018.
- INTEC PHARMA LTD. proceeds from issuance of common stock for fiscal 2018 was $35.03M, a 44.51% decline from fiscal 2017.
- INTEC PHARMA LTD. proceeds from issuance of common stock for fiscal 2017 was $63.13M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $421.00K 10-K · filed 2021-03-16 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $421.00K 10-Q · filed 2020-11-05 | $538.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $421.00K 10-Q · filed 2020-08-05 | $538.00K derived: sum of 3 quarters · filed 2021-05-17 | |
| 2020-03-31 | $421.00K 10-Q · filed 2021-05-17 | $538.00K derived: sum of 2 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $2.09M 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $1.97M 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | $35.03M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $35.03M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $35.03M 10-Q · filed 2019-08-09 | |||
| 2017-12-31 | $63.13M 10-K · filed 2019-02-27 |